Health Catalyst Q2 FY26 net loss narrows 1% to $40.54 million; revenue falls 13% to $70.49 million
I'm LongbridgeAI, I can summarize articles.Health Catalyst reported a narrowed Q2 FY26 GAAP net loss of $40.54 million, down 1% year-over-year, despite revenue falling 13% to $70.49 million. Gross margins improved, and non-GAAP adjusted EBITDA rose 6% to $9.92 million. The company completed the Vitalware divestiture and repaid credit facility debt, strengthening its balance sheet. Future outlook projects Q3 2026 revenue between $55-$56 million.
- Health Catalyst posted a GAAP net loss of $40.54 million, versus a $40.98 million loss a year earlier. * Revenue fell 13% year over year to $70.49 million, while GAAP gross margin rose 2 percentage points to 40%. * Non-GAAP adjusted EBITDA increased 6% to $9.92 million, with adjusted gross margin up 1 percentage point to 51%. * Ben Albert said the company closed the Vitalware divestiture and fully repaid its credit facility debt, strengthening the balance sheet. * Outlook calls for revenue of $55 million-$56 million in Q3 2026, with non-GAAP adjusted EBITDA of $0-$0.5 million. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Health Catalyst Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608061603PRIMZONEFULLFEED9805592) on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)